scholarly journals Survival update in randomized phase II trial of S-1/cisplatin (SP) or docetaxel/cisplatin (DP) with concurrent thoracic radiotherapy for inoperable stage III non-small cell lung cancer (NSCLC)-TORG1018

2018 ◽  
Vol 29 ◽  
pp. viii491 ◽  
Author(s):  
Y. Takiguchi ◽  
K. Yamada ◽  
H. Tanaka ◽  
K. Kubota ◽  
K. Kishi ◽  
...  
2004 ◽  
Vol 10 (15) ◽  
pp. 5022-5026 ◽  
Author(s):  
Martin J. Edelman ◽  
Joseph I. Clark ◽  
Kari Chansky ◽  
Kathy Albain ◽  
Nirmala Bhoopalam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document